Kidney cancer, Renal cell cancer
Results
Phase 2/3
This trial was looking at a drug called naptumomab estafenatox (also known as ABR-217620) alongside interferon for a type of kidney cancer called renal cell cancer. It was for people who had renal cell cancer that could not be removed with surgery or had spread to another part of the body.
Recruitment start: 1 May 2007
Recruitment end: 19 May 2009
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Professor Robert Hawkins
Active Biotech AB
Last reviewed: 05 Oct 2016
CRUK internal database number: 991
About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education
What to ask your doctor about clinical trials.
Meet and chat to other cancer people affected by cancer.
Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.
